Skip to menu Skip to content Skip to footer
Dr Melanie Robitaille
Dr

Melanie Robitaille

Email: 
Phone: 
+61 7 334 61856

Overview

Background

Dr Melanie Robitaille is a Senior Post-Doctoral Researcher working with the Calcium Signalling in Therapeutics Team (CaSTT) in the School of Pharmacy. This team specializes in the development and application of novel methodologies and cellular assays in drug discovery, including the use of genetically encoded indicator for high-content imaging in live cells.

Her interests are to elucidate how calcium signals are remodelled in disease states, to identify calcium transporters as new therapeutic targets and to develop molecular and cellular screening tools to be used in drug development programs. She has an established profile in cellular and molecular biology, with high expertise in plasmid cloning, lentiviral transduction and the use of CRISPR/Cas9 to modulate gene expression.

Availability

Dr Melanie Robitaille is:
Not available for supervision

Qualifications

  • Doctor of Philosophy, Université de Montréal

Works

Search Professor Melanie Robitaille’s works on UQ eSpace

80 works between 2006 and 2025

1 - 20 of 80 works

2025

Journal Article

ORAI1α and ORAI1β have differential sensitivity to extracellular pH

Robitaille, Mélanie, McCullough, Michael H., So, Choon Leng, Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2025). ORAI1α and ORAI1β have differential sensitivity to extracellular pH. Biochimica et Biophysica Acta. Molecular Cell Research, 1872 (7) 120010, 1-11. doi: 10.1016/j.bbamcr.2025.120010

ORAI1α and ORAI1β have differential sensitivity to extracellular pH

2025

Journal Article

Cancer Progression and the Calcium Signaling Toolkit: Expanding Dimensions and Perspectives

Robitaille, Mélanie and Monteith, Gregory R. (2025). Cancer Progression and the Calcium Signaling Toolkit: Expanding Dimensions and Perspectives. Cold Spring Harbor Perspectives in Biology a041767, 1-17. doi: 10.1101/cshperspect.a041767

Cancer Progression and the Calcium Signaling Toolkit: Expanding Dimensions and Perspectives

2025

Other Outputs

FLIPR raw data

Robitaille, Melanie, Roberts-Thomson, Sarah and Monteith, Gregory (2025). FLIPR raw data. The University of Queensland. (Dataset) doi: 10.48610/e3133eb

FLIPR raw data

2024

Conference Publication

The effect of enhanced Ca2+ influx by IA65 on ORAI1-mediated Interleukin-6 gene expression in breast cancer cells

Han, Jihye, Forouz, Farzaneh, Roberts-Thomson, Sarah J., Monteith, Gregory R., Bong, Alice H. L. and Robitaille, Melanie (2024). The effect of enhanced Ca2+ influx by IA65 on ORAI1-mediated Interleukin-6 gene expression in breast cancer cells. ASCEPT, APFP & APSA Joint Conference, Melbourne, VIC, Australia, 1 - 4 December 2024.

The effect of enhanced Ca2+ influx by IA65 on ORAI1-mediated Interleukin-6 gene expression in breast cancer cells

2024

Conference Publication

Developing a cell-based model to assess the effect of intermittent dabrafenib exposure on melanoma cells

Nagarajan, Anika, Forouz, Farzaneh, Roberts-Thomson, Sarah J., Monteith, Gregory R., Schaider, Helmut and Robitaille, Melanie (2024). Developing a cell-based model to assess the effect of intermittent dabrafenib exposure on melanoma cells. ASCEPT, APFP & APSA Joint Conference, Melbourne, VIC, Australia, 1 - 4 December 2024.

Developing a cell-based model to assess the effect of intermittent dabrafenib exposure on melanoma cells

2024

Conference Publication

Bivalent peptide agonists targeting peripheral Kappa and Nociceptin heterodimer opioid receptors for the treatment of pain and opioid use disorder

Habib, Muhaimin, Saifuddin, Danial, Robitaille, Mélanie and Cabot, Peter (2024). Bivalent peptide agonists targeting peripheral Kappa and Nociceptin heterodimer opioid receptors for the treatment of pain and opioid use disorder. ASCEPT, APFP & APSA Joint Conference, Melbourne, VIC Australia, 1 - 4 December 2024.

Bivalent peptide agonists targeting peripheral Kappa and Nociceptin heterodimer opioid receptors for the treatment of pain and opioid use disorder

2024

Conference Publication

Targeting peripheral mu and delta heterodimer receptors with bivalent opioid peptides

Zhang, Junkai, Robitaille, Melanie, Saifuddin, Danial, Ross, Benjamin and Cabot, Peter (2024). Targeting peripheral mu and delta heterodimer receptors with bivalent opioid peptides. ASCEPT, APFP & APSA Joint Conference, Melbourne, VIC Australia, 1 - 4 December 2024.

Targeting peripheral mu and delta heterodimer receptors with bivalent opioid peptides

2024

Journal Article

TMCO1 is upregulated in breast cancer and regulates the response to pro-apoptotic agents in breast cancer cells

Bong, Alice H. L., Robitaille, Mélanie, Lin, Sichun, McCart-Reed, Amy, Milevskiy, Michael, Angers, Stéphane, Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2024). TMCO1 is upregulated in breast cancer and regulates the response to pro-apoptotic agents in breast cancer cells. Cell Death Discovery, 10 (1) 421, 1-12. doi: 10.1038/s41420-024-02183-0

TMCO1 is upregulated in breast cancer and regulates the response to pro-apoptotic agents in breast cancer cells

2024

Conference Publication

Understanding changes in host cell calcium signalling during coronavirus infection

Chan, Shao Ming, Monteith, Gregory, Roberts-Thomson, Sarah, Labzin, Larisa and Robitaille, Mélanie (2024). Understanding changes in host cell calcium signalling during coronavirus infection. OPTIONS XII for the Control of Influenza, Brisbane, QLD Australia, 29 September - 2 October 2024.

Understanding changes in host cell calcium signalling during coronavirus infection

2024

Conference Publication

ORAI1 isoforms have differential sensitivity to extracellular pH

Robitaille, Melanie, McCullough, Michael H., So, Choon Leng, Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2024). ORAI1 isoforms have differential sensitivity to extracellular pH. BioMolecular Horizons 2024, Melbourne, VIC, Australia, 22-26 September 2024.

ORAI1 isoforms have differential sensitivity to extracellular pH

2024

Conference Publication

Calcium signaling in the breast cancer microenvironment

Forouz, Farzaneh, Bong, Alice H., Robitaille, Melanie, Roberts-Thomson, Sarah and Monteith, Gregory (2024). Calcium signaling in the breast cancer microenvironment. BioMolecular Horizons 2024, Melbourne, VIC Australia, 22-26 September 2024.

Calcium signaling in the breast cancer microenvironment

2024

Conference Publication

A high-throughput method to monitor live-cell calcium signalling changes during coronavirus infection.

Chan, Shao Ming, Monteith, Gregory, Roberts-Thomson, Sarah, Labzin, Larisa and Robitaille, Mélanie (2024). A high-throughput method to monitor live-cell calcium signalling changes during coronavirus infection.. 17th International Meeting of the European Calcium Society, Cambridge, United Kingdom, 31 August - 4 September 2024.

A high-throughput method to monitor live-cell calcium signalling changes during coronavirus infection.

2024

Conference Publication

A calcium influx pathway regulates adaptive melanoma drug tolerance

Guan, Yimeng, Robitaille, Melanie, Torrano, Joachim, Haass, Nikolas, Roberts-Thomson, Sarah, Monteith, Gregory and Schaider, Helmut (2024). A calcium influx pathway regulates adaptive melanoma drug tolerance. ASDR 2024 Annual Scientific Meeting, Sydney, NSW Australia, 18-20 July 2024.

A calcium influx pathway regulates adaptive melanoma drug tolerance

2024

Conference Publication

Exploring calcium signalling remodelling during adaptive cancer drug tolerance

Robitaille, Melanie, Schaider, Helmut, Monteith, Gregory and Roberts-Thomson, Sarah (2024). Exploring calcium signalling remodelling during adaptive cancer drug tolerance. Calcium Signaling- Gordon Research Conference, Barga, Lucca, Italy, 30 June - 5 July 2024.

Exploring calcium signalling remodelling during adaptive cancer drug tolerance

2024

Journal Article

Cellular geometry and epithelial-mesenchymal plasticity intersect with PIEZO1 in breast cancer cells

So, Choon Leng, Robitaille, Mélanie, Sadras, Francisco, McCullough, Michael H., Milevskiy, Michael J. G., Goodhill, Geoffrey J., Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2024). Cellular geometry and epithelial-mesenchymal plasticity intersect with PIEZO1 in breast cancer cells. Communications Biology, 7 (1) 467, 1-14. doi: 10.1038/s42003-024-06163-z

Cellular geometry and epithelial-mesenchymal plasticity intersect with PIEZO1 in breast cancer cells

2023

Conference Publication

Developing a human cell model to study calcium signalling during coronavirus infection.

Chan, Shao Ming, Monteith, Gregory, Roberts-Thomson, Sarah, Labzin, Larisa and Robitaille, Mélanie (2023). Developing a human cell model to study calcium signalling during coronavirus infection.. ASCEPT Annual Scientific Meeting, Sydney, NSW, Australia, 20-23 November 2023.

Developing a human cell model to study calcium signalling during coronavirus infection.

2023

Conference Publication

Calcium signaling and the breast cancer microenvironment

Forouz, Farzaneh, Bong, Alice H. L., Gieniec, Krystyna A., Sadras, Francisco, Robitaille, Mélanie, Roberts- Thomson, Sarah J., Davis, Felicity M. and Monteith, Gregory R. (2023). Calcium signaling and the breast cancer microenvironment. ASCEPT Annual Scientific Meeting, Sydney, NSW Australia, 20-23 November 2023.

Calcium signaling and the breast cancer microenvironment

2023

Conference Publication

Gene expression of calcium signalling modulators in SARS-CoV-2 infection

Akison, Mia C., Eschke, Kathrin, Monteith, Gregory, Roberts-Thomson, Sarah, Labzin, Larisa and Robitaille, Mélanie (2023). Gene expression of calcium signalling modulators in SARS-CoV-2 infection. ASCEPT Annual Scientific, Sydney, NSW, Australia, 20-23 November 2023.

Gene expression of calcium signalling modulators in SARS-CoV-2 infection

2023

Conference Publication

Exploring calcium signalling remodelling during adaptive cancer drug tolerance

Robitaille, Mélanie, Schaider, Helmut, Roberts-Thomson, Sarah and Monteith, Gregory (2023). Exploring calcium signalling remodelling during adaptive cancer drug tolerance. ASCEPT Annual Scientific Meeting, Sydney, NSW Australia, 20-23 November 2023.

Exploring calcium signalling remodelling during adaptive cancer drug tolerance

2023

Journal Article

The intersection between cysteine proteases, Ca2+ signalling and cancer cell apoptosis

Hua, Trinh, Robitaille, Mélanie, Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2023). The intersection between cysteine proteases, Ca2+ signalling and cancer cell apoptosis. Biochimica et Biophysica Acta - Molecular Cell Research, 1870 (7) 119532, 1-13. doi: 10.1016/j.bbamcr.2023.119532

The intersection between cysteine proteases, Ca2+ signalling and cancer cell apoptosis

Funding

Current funding

  • 2025 - 2028
    A First-in-Class Calcium Channel Inhibitor for the Treatment of Advanced Metastatic Prostate Cancers Resistant to Next-Generation Antiandrogen Therapy
    United States Congressionally Directed Medical Research Programs - Prostate Cancer Research Program
    Open grant
  • 2023 - 2026
    A calcium influx pathway regulates adaptive cancer drug tolerance
    NHMRC IDEAS Grants
    Open grant

Past funding

  • 2023 - 2024
    A calcium influx pathway regulates adaptive cancer drug tolerance
    TdC Pioneering Grant
    Open grant
  • 2022 - 2025
    An active ion transport pathway exploited by coronaviruses
    ARC Discovery Projects
    Open grant

Supervision

Availability

Dr Melanie Robitaille is:
Not available for supervision

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Dr Melanie Robitaille's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au